Optiver Holding
KRYS icon

Optiver Holding’s Krystal Biotech KRYS Stock Holding History

Optiver Holding’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.4K Buy
+211
New +$63K ﹤0.01% 1078
2026
Q1 		– Sell
-1
Closed -$247 – 2548
2025
Q4 		$247 Buy
+1
New +$210 ﹤0.01% 2339

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Optiver Holding's KRYS Position: Q2 2026 in Review

Optiver Holding opened a new position in Krystal Biotech (KRYS) in Q2 2026: 211 shares worth $78.4K. The stake represents ﹤0.01% of the portfolio and ranks #1078 among its holdings. This is a return to the name: Optiver Holding previously reported a position in KRYS as recently as Q4 2025.

Optiver Holding first reported a position in KRYS in Q4 2025 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Optiver Holding held 211 shares of Krystal Biotech worth $78.4K as of Q2 2026.
  • Krystal Biotech was a new Optiver Holding position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1078 holding.
  • Optiver Holding first reported a position in Krystal Biotech in Q4 2025 and has held it in 2 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.